NAFLD

Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals

A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH

The Effects of Glucagon on Hepatic Metabolism

Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters.

Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease

Effects of Tomato Consumption on Steatosis, Intestinal Function and Glucose and Lipid Metabolism in Subjects With NAFLD

Bicalutamide Therapy in Young Women With NAFLD and PCOS

Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver Disease

Androgens and NAFLD Longitudinal Cohort Study

RE and Probiotics in MAFLD/NAFLD

Accurate Point of Care Liver Disease Diagnostics (Phase 2)

Target of Suv420h1/2 in Hepatocytes

Short and Long Term Clinical and Patient-Reported Outcomes Associated With Intragastric Balloon Placement in Patients With Nonalcoholic Fatty Liver Disease

Effects of Two Different Exercise Programs and Diet in Obese Subjects With NAFLD

Assessment of Fatty Liver With Thermo-acoustic Device

Quantifying Body Composition and Liver Disease in Children Using Free-Breathing MRI and MRE

Effect of VLCD on the Reduction of Liver Steatosis and Fibrosis in Subjects With Obesity and NAFLD

GLP-1 RA on Liver OMICS in MASLD

Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD

A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)